Furthermore, CRTC3–MAML2 tends to have a smaller tumor size and better prognosis than does CRTC1–MAML2, although these data have no statistical significance because of the low number of CRTC3–MAML2 cases (44, 45). The gene discussed is CRTC3; the disease is neoplasm.